(Reuters) -Australian biotech firm CSL said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived ...

On the YouTube channel of Himchan Hospital, the treatment of self-platelet-rich plasma (PRP) intraarticular injections that ...

Sometimes what works for humans can also be effective in our dogs and cats. In this segment, Timmy Geocaris from Buddy’s Vets ...

“Our data shows that as many as 20% of breast cancer survivors on aromatase inhibitors will stop taking their medication ...

Former Try Guys YouTuber Ned Fulmer exclusively opened up to Us Weekly about a health battle he has faced for more than a ...

Ned Fulmer has revealed he was diagnosed with multiple sclerosis in 2013 and kept his health battle a secret for over a ...

ADMA Biologics has demonstrated impressive operational performance in its latest quarterly report, but the company's true ...

According to Nova One Advisor, the global plasma fractionation market size is calculated at USD 38.28 billion in 2025 and is expected to be worth around USD 80.44 billion by 2034, growing at a ...

Lower baseline low-density lipoprotein cholesterol levels are linked to a higher risk for incident type 2 diabetes, largely ...

Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...

The regulator has received reports that a group of patients treated with Adzynma had neutralizing antibodies against the ...